SAB Biotherapeutics, Inc. Profile Avatar - Palmy Investing

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that…

Biotechnology
US, Sioux Falls [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SABS's Analysis
CIK: 1833214 CUSIP: 78397T103 ISIN: US78397T2024 LEI: - UEI: -
Secondary Listings
SABS has no secondary listings inside our databases.